Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine [clinicaltrials_resource:c0ed9ed0fb555a27d4f62cad9c783822]
intervention [clinicaltrials_vocabulary:intervention]
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine [clinicaltrials_resource:c0ed9ed0fb555a27d4f62cad9c783822]
Bio2RDF identifier
c0ed9ed0fb555a27d4f62cad9c783822
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c0ed9ed0fb555a27d4f62cad9c783822
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Quadrivalent HPV vaccine (6,11 ...... month 6, 7 months of treatment
intervention name [clinicaltrials_vocabulary:intervention-name]
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine
identifier
clinicaltrials_resource:c0ed9ed0fb555a27d4f62cad9c783822
title
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine
@en
type
label
Quadrivalent Human Papillomavi ...... d9ed0fb555a27d4f62cad9c783822]
@en